These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23890075)

  • 1. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
    Mwintshi K; Brennan DC
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.
    Martin JM; Danziger-Isakov LA
    Pediatr Transplant; 2011 May; 15(3):229-36. PubMed ID: 21199215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients.
    Campbell AL; Herold BC
    Pediatr Transplant; 2004 Dec; 8(6):619-27. PubMed ID: 15598337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD
    Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus in transplantation - challenging the status quo.
    Fishman JA; Emery V; Freeman R; Pascual M; Rostaing L; Schlitt HJ; Sgarabotto D; Torre-Cisneros J; Uknis ME
    Clin Transplant; 2007; 21(2):149-58. PubMed ID: 17425738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
    Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
    Paya CV
    Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
    Melendez D; Razonable RR
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
    Singh N
    J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and impact of CMV prevention following pediatric organ transplantation.
    Allen UD
    Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.